ARCHIVES

ASCO Releases Abstracts To 25,000, But Adds Warning On Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 16 | April 19, 2002

Download PDF Visit The Full Archive

Related Articles

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

July 1, 1994

Duke wins Avon-NCI funding.

October 31, 2003

NCI “Leadership Vacuum” Deepened?

December 22, 1994

DCBDC board Okays RFA concept On AIDS Lymphoma

March 26, 1993

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

April 29, 1988

International Working Group Suggests Earlier Endpoints For HPV Vaccine Trials

August 29, 2014